Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis.

Lehane PB, Lacey S, Hessey EW, Jahreis A.

Ann Rheum Dis. 2014 Oct;73(10):1906-8. doi: 10.1136/annrheumdis-2014-205474. Epub 2014 Jul 29. No abstract available.

2.

Using registries to identify adverse events in rheumatic diseases.

Lionetti G, Kimura Y, Schanberg LE, Beukelman T, Wallace CA, Ilowite NT, Winsor J, Fox K, Natter M, Sundy JS, Brodsky E, Curtis JR, Del Gaizo V, Iyasu S, Jahreis A, Meeker-O'Connell A, Mittleman BB, Murphy BM, Peterson ED, Raymond SC, Setoguchi S, Siegel JN, Sobel RE, Solomon D, Southwood TR, Vesely R, White PH, Wulffraat NM, Sandborg CI.

Pediatrics. 2013 Nov;132(5):e1384-94. doi: 10.1542/peds.2013-0755. Epub 2013 Oct 21. Review.

3.

Integrated safety in tocilizumab clinical trials.

Schiff MH, Kremer JM, Jahreis A, Vernon E, Isaacs JD, van Vollenhoven RF.

Arthritis Res Ther. 2011;13(5):R141. doi: 10.1186/ar3455. Epub 2011 Sep 1.

4.

A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis.

Cardiel MH, Tak PP, Bensen W, Burch FX, Forejtova S, Badurski JE, Kakkar T, Bevirt T, Ni L, McCroskery E, Jahreis A, Zack DJ.

Arthritis Res Ther. 2010;12(5):R192. doi: 10.1186/ar3163. Epub 2010 Oct 15.

7.

Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency.

Rump JA, Jahreis A, Schlesier M, Dräger R, Melchers I, Peter HH.

Clin Exp Immunol. 1992 Aug;89(2):204-10.

Supplemental Content

Loading ...
Support Center